Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2

EU orphan designation number: EU/3/17/1838   
Active ingredient: Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2
Indication: Treatment of pancreatic cancer
Sponsor: Opsona Therapeutics Limited
2nd floor, Ashford House, Tara Street, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/03/2017 Orphan designation EMA/OD/273/16 (2017)1504 of 27/02/2017